This study will build on lessons learned from the CHOICES pilot study (CTN-0055) and to advance understanding of XR-NTX adoption in HIV primary care settings. HIV primary care clinics are being selected to participate in an open-label trial of office-based XR-NTX in HIV-infected participants with untreated opioid use disorder or alcohol use disorders.
11ae82847e7f2075593c456dc429647e
Todd Korthuis, M.D., M.P.H.
Associate Professor of Medicine
Oregon Health & Science University
Department of Public Health & Preventive Medicine
3181 Southwest Sam Jackson Park Road, L475
Portland, OR 97239-3098
United States
korthuis@ohsu.edu
Todd Korthuis, M.D., M.P.H.
Associate Professor of Medicine
Oregon Health & Science University
3181 Southwest Sam Jackson Park Road, L475, Portland, OR, 97239-3098, US
CTN-0067
Participating Sites
- The CORE Center, Illinois
- University of British Columbia , Vancouver, Canada
completed